MedTrace Logo

A Study of BRT-FC-83C for the Treatment of Atopic Dermatitis

NCT00883311 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2010-08-31

No results posted yet for this study

Summary

The purpose of the study is to determine whether the topical application of BRT-FC-83C is effective in the treatment of mild to moderate atopic dermatitis.

Conditions

Interventions

DEVICE

BRT-FC-83C

BRT-FC-83C is a topical cream to treat atopic dermatitis. It is applied topically, twice a day, to the atopic dermatitis skin lesion for six weeks.

Sponsors & Collaborators

  • Biomed Research & Technologies, Inc.

    lead INDUSTRY

Principal Investigators

  • Nathan S. Trookman, M.D. · Thomas J. Stephens & Associates, Inc.

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-01-31
Primary Completion
2009-07-31
Completion
2009-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00883311 on ClinicalTrials.gov